Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2017, Article ID 2606271, 20 pages
https://doi.org/10.1155/2017/2606271
Review Article

Skin Cancer and Its Treatment: Novel Treatment Approaches with Emphasis on Nanotechnology

1Faculty of Medicine, Institute of Biomedical Sciences, University of Maribor, Taborska Ulica 8, SI-2000 Maribor, Slovenia
2Institute of Oncology Ljubljana, Zaloška 2, SI-1000 Ljubljana, Slovenia

Correspondence should be addressed to Uroš Maver; is.mu@revam.soru

Received 13 October 2016; Accepted 23 January 2017; Published 19 February 2017

Academic Editor: William Yu

Copyright © 2017 Kristjan Orthaber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D'Orazio, S. Jarrett, A. Amaro-Ortiz, and T. Scott, “UV radiation and the skin,” International Journal of Molecular Sciences, vol. 14, no. 6, pp. 12222–12248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. F. Simões, J. J. S. Sousa, and A. A. C. C. Pais, “Skin cancer and new treatment perspectives: a review,” Cancer Letters, vol. 357, no. 1, pp. 8–42, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. Medical Center University of California, Nonmelanoma Skin Cancer vs. Melanoma, 2007.
  4. D. L. Narayanan, R. N. Saladi, and J. L. Fox, “Ultraviolet radiation and skin cancer,” International Journal of Dermatology, vol. 49, no. 9, pp. 978–986, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Rhee, B. A. Matthews, M. Neuburg, B. R. Logan, M. Burzynski, and A. B. Nattinger, “The skin cancer index: clinical responsiveness and predictors of quality of life,” The Laryngoscope, vol. 117, no. 3, pp. 399–405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. O'Driscoll, J. McMorrow, P. Doolan et al., “Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays,” Molecular Cancer, vol. 5, article 74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. L. H. Goldberg, “Basal cell carcinoma,” Lancet, vol. 347, no. 9002, pp. 663–667, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Lomas, J. Leonardi-Bee, and F. Bath-Hextall, “A systematic review of worldwide incidence of nonmelanoma skin cancer,” British Journal of Dermatology, vol. 166, no. 5, pp. 1069–1080, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Garbe, D. Schadendorf, W. Stolz et al., “Short German guidelines: malignant melanoma,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 6, no. 1, pp. S9–S15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Slora, “Maligni melanom (C43): Slora,” 2016, http://www.slora.si/c/document_library/get_file?uuid=c2e610c7-5353-40dd-93e9-1b1b2320e3e1&groupId=11561.
  11. S. Sachdeva, “Fitzpatrick skin typing: applications in dermatology,” Indian Journal of Dermatology, Venereology and Leprology, vol. 75, no. 1, pp. 93–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. B. Fitzpatrick and A. J. Sober, “Sunlight and skin cancer,” New England Journal of Medicine, vol. 313, no. 13, pp. 818–820, 1985. View at Publisher · View at Google Scholar · View at Scopus
  13. Onkološki Inštitut Ljubljana, Rak v Sloveniji 2012, Edited by M. Žakelj Primic, Onkološki inštitut Ljubljana, Epidemiologija in Register Raka, Register Raka Republike Slovenije, Ljubljana, Slovenia, 2015.
  14. J. Califano and M. Nance, “Malignant Melanoma,” Facial Plastic Surgery Clinics of North America, vol. 17, no. 3, pp. 337–348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M.-M. Chren, J. S. Torres, S. E. Stuart, D. Bertenthal, R. J. Labrador, and W. J. Boscardin, “Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study,” Archives of Dermatology, vol. 147, no. 5, pp. 540–546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Samarasinghe and V. Madan, “Nonmelanoma skin cancer,” Journal of Cutaneous and Aesthetic Surgery, vol. 5, no. 1, pp. 3–10, 2012. View at Publisher · View at Google Scholar
  17. NICE, Melanoma: Assessment and Management/Guidance and Guidelines, NICE-The National Institute for Health and Care Excellence, London, UK, 2015.
  18. S. Karjalainen, H. Salo, and L. Teppo, “Basal cell and squamous cell carcinoma of the skin in Finland,” International Journal of Dermatology, vol. 28, no. 7, pp. 445–450, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Czarnecki, C. Meehan, T. O'Brien, S. Leahy, and C. Nash, “The changing face of skin cancer in Australia,” International Journal of Dermatology, vol. 30, no. 10, pp. 715–717, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Allison Jr., “Radiation-induced basal-cell carcinoma,” The Journal of Dermatologic Surgery and Oncology, vol. 10, no. 3, pp. 200–205, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. J. B. Howell, “Nevoid basal cell carcinoma syndrome. Profile of genetic and environmental factors in oncogenesis,” Journal of the American Academy of Dermatology, vol. 11, no. 1, pp. 98–104, 1984. View at Publisher · View at Google Scholar · View at Scopus
  22. T. J. Wieman, E. H. Shively, and T. M. Woodcock, “Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case report,” Cancer, vol. 52, no. 9, pp. 1583–1585, 1983. View at Publisher · View at Google Scholar · View at Scopus
  23. N. R. Rowell, “A follow-up study of superficial radiotherapy for benign dermatoses: recommendations for the use of X-rays in dermatology,” British Journal of Dermatology, vol. 88, no. 6, pp. 583–590, 1973. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Accardi and T. Gheit, “Cutaneous HPV and skin cancer,” La Presse Médicale, vol. 43, no. 12, part 2, pp. e435–e443, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Bridges, “Sunlight, DNA damage and skin cancer: a new perspective,” Japanese Journal of Cancer Research, vol. 81, no. 2, pp. 105–107, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. K. H. Kraemer, M. M. Lee, and J. Scotto, “Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases,” Archives of Dermatology, vol. 123, no. 2, pp. 241–250, 1987. View at Publisher · View at Google Scholar · View at Scopus
  27. J. D. Brewer, O. R. Colegio, P. K. Phillips et al., “Incidence of and risk factors for skin cancer after heart transplant,” Archives of Dermatology, vol. 145, no. 12, pp. 1391–1396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Silverberg, W. Leyden, E. M. Warton, C. P. Quesenberry Jr., E. A. Engels, and M. M. Asgari, “HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer,” Journal of the National Cancer Institute, vol. 105, no. 5, pp. 350–360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Harwood, T. Surentheran, P. Sasieni et al., “Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin,” British Journal of Dermatology, vol. 150, no. 5, pp. 949–957, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Engel, M.-L. Johnson, and S. G. Haynes, “Health effects of sunlight exposure in the United States: results from the first national health and nutrition examination survey, 1971–1974,” Archives of Dermatology, vol. 124, no. 1, pp. 72–79, 1988. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Marks, G. Rennie, and T. Selwood, “Malignant transformation of solar keratoses to squamous cell carcinoma,” The Lancet, vol. 331, no. 8589, pp. 795–797, 1988. View at Publisher · View at Google Scholar · View at Scopus
  32. B. K. Armstrong and C. D. J. Holman, “Malignant melanoma of the skin,” Bulletin of the World Health Organization, vol. 65, no. 2, pp. 245–252, 1987. View at Google Scholar · View at Scopus
  33. C. D. J. Holman and B. K. Armstrong, “Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types,” Journal of the National Cancer Institute, vol. 73, no. 1, pp. 75–82, 1984. View at Publisher · View at Google Scholar · View at Scopus
  34. D. G. Coit, R. Andtbacka, C. J. Anker et al., “Melanoma,” Journal of the National Comprehensive Cancer Network, vol. 10, no. 3, pp. 366–400, 2012. View at Google Scholar
  35. P. Huang, X.-D. Yang, S.-D. Chen, and Q. Xiao, “The association between Parkinson's disease and melanoma: a systematic review and meta-analysis,” Translational Neurodegeneration, vol. 4, article 21, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Breslow, “Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma,” Annals of Surgery, vol. 172, no. 5, pp. 902–908, 1970. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Dummer, A. Hauschild, N. Lindenblatt, G. Pentheroudakis, and U. Keilholz, “Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 26, supplement 5, pp. v126–v132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Sekulic, M. R. Migden, A. E. Oro et al., “Efficacy and safety of vismodegib in advanced basal-cell carcinoma,” New England Journal of Medicine, vol. 366, no. 23, pp. 2171–2179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. B. P. Singh and A. K. S. Salama, “Updates in therapy for advanced melanoma,” Cancers, vol. 8, no. 1, article 17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. R. D. Carvajal, C. R. Antonescu, J. D. Wolchok et al., “KIT as a therapeutic target in metastatic melanoma,” The Journal of the American Medical Association, vol. 305, no. 22, pp. 2327–2334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. D. Carvajal, D. P. Lawrence, J. S. Weber et al., “Phase II study of nilotinib in melanoma harboring KIT alterations following progression to prior KIT inhibition,” Clinical Cancer Research, vol. 21, no. 10, pp. 2289–2296, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Millet, A. R. Martin, C. Ronco, S. Rocchi, and R. Benhida, “Metastatic melanoma: insights into the evolution of the treatments and future challenges,” Medicinal Research Reviews, vol. 37, no. 1, pp. 98–148, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. F. S. Hodi, S. J. O'Day, D. F. McDermott et al., “Improved survival with ipilimumab in patients with metastatic melanoma,” The New England Journal of Medicine, vol. 363, no. 8, pp. 711–723, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Cancer Research UK, Skin Cancer Prevention, Cancer Research UK, 2015.
  45. C. Dianzani, G. P. Zara, G. Maina et al., “Drug delivery nanoparticles in skin cancers,” BioMed Research International, vol. 2014, Article ID 895986, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. L. S. Wang, M. C. Chuang, and J. A. Ho, “Nanotheranostics—a review of recent publications,” International Journal of Nanomedicine, vol. 7, pp. 4679–4695, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Xie, S. Lee, and X. Chen, “Nanoparticle-based theranostic agents,” Advanced Drug Delivery Reviews, vol. 62, no. 11, pp. 1064–1079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Safari and Z. Zarnegar, “Advanced drug delivery systems: nanotechnology of health design A review,” Journal of Saudi Chemical Society, vol. 18, no. 2, pp. 85–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. D. H. Nguyen, J. S. Lee, J. H. Choi, K. M. Park, Y. Lee, and K. D. Park, “Hierarchical self-assembly of magnetic nanoclusters for theranostics: tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery,” Acta Biomaterialia, vol. 35, pp. 109–117, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. Q. Chen, X. Wang, C. Wang, L. Feng, Y. Li, and Z. Liu, “Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy,” ACS Nano, vol. 9, no. 5, pp. 5223–5233, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Wu, L. Zhao, X. Xu et al., “Hydrophobic cysteine poly(disulfide)-based redox-hypersensitive nanoparticle platform for cancer theranostics,” Angewandte Chemie—International Edition, vol. 54, no. 32, pp. 9218–9223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Maeda, K. Greish, and J. Fang, “The EPR effect and polymeric drugs: a paradigm shift for cancer chemotherapy in the 21st century,” in Polymer Therapeutics II, R. Satchi-Fainaro and R. Duncan, Eds., pp. 103–121, Springer, Berlin, Germany, 2006. View at Google Scholar
  53. U. Prabhakar, H. Maeda, R. K. Jain et al., “Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology,” Cancer Research, vol. 73, no. 8, pp. 2412–2417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Hao, L. Wang, B. Zhang et al., “Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application,” Nanotechnology, vol. 27, no. 2, Article ID 025101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Ma, Y. Liu, M. Shi et al., “Theranostic, pH-responsive, doxorubicin-loaded nanoparticles inducing active targeting and apoptosis for advanced gastric cancer,” Biomacromolecules, vol. 16, no. 12, pp. 4022–4031, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. S. S. Kelkar and T. M. Reineke, “Theranostics: combining imaging and therapy,” Bioconjugate Chemistry, vol. 22, no. 10, pp. 1879–1903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Ding and F. Wu, “Image guided biodistribution and pharmacokinetic studies of theranostics,” Theranostics, vol. 2, no. 11, pp. 1040–1053, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. W. Xiao, X. Zeng, H. Lin, K. Han, H.-Z. Jia, and X.-Z. Zhang, “Dual stimuli-responsive multi-drug delivery system for the individually controlled release of anti-cancer drugs,” Chemical Communications, vol. 51, no. 8, pp. 1475–1478, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. K.-N. Yang, C.-Q. Zhang, W. Wang, P. C. Wang, J.-P. Zhou, and X.-J. Liang, “pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment,” Cancer Biology and Medicine, vol. 11, no. 1, pp. 34–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Jeetah, A. Bhaw-Luximon, and D. Jhurry, “Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment,” Journal of Biomedical Nanotechnology, vol. 10, no. 9, pp. 1810–1840, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Qin, J. Chen, Y. Bi et al., “Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle,” Acta Biomaterialia, vol. 17, pp. 201–209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. I. A. Khawar, J. H. Kim, and H.-J. Kuh, “Improving drug delivery to solid tumors: priming the tumor microenvironment,” Journal of Controlled Release, vol. 201, pp. 78–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Sefidgar, M. Soltani, K. Raahemifar, H. Bazmara, S. M. M. Nayinian, and M. Bazargan, “Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors,” Journal of Biological Engineering, vol. 8, no. 1, article no. 12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Kim, K. Bell, S. A. Mousa, and J. A. Varner, “Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin,” The American Journal of Pathology, vol. 156, no. 4, pp. 1345–1362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. B. St Croix, C. Rago, V. Velculescu et al., “Genes expressed in human tumor endothelium,” Science, vol. 289, no. 5482, pp. 1197–1202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. D. F. Emerich and C. G. Thanos, “Targeted nanoparticle-based drug delivery and diagnosis,” Journal of Drug Targeting, vol. 15, no. 3, pp. 163–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Arap, R. Pasqualini, and E. Ruoslahti, “Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model,” Science, vol. 279, no. 5349, pp. 377–380, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. M. P. Turunen, H. L. Puhakka, J. K. Koponen et al., “Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer,” Molecular Therapy, vol. 6, no. 3, pp. 306–312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. F. Curnis, A. Sacchi, and A. Corti, “Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration,” The Journal of Clinical Investigation, vol. 110, no. 4, pp. 475–482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. J. D. Hood, M. Bednarski, R. Frausto et al., “Tumor regression by targeted gene delivery to the neovasculature,” Science, vol. 296, no. 5577, pp. 2404–2407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. P. M. Winter, S. D. Caruthers, A. Kassner et al., “Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel αvβ3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging,” Cancer Research, vol. 63, no. 18, pp. 5838–5843, 2003. View at Google Scholar · View at Scopus
  72. M. E. Åkerman, W. C. W. Chan, P. Laakkonen, S. N. Bhatia, and E. Ruoslahti, “Nanocrystal targeting in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 20, pp. 12617–12621, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Pastorino, C. Brignole, D. Marimpietri et al., “Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy,” Cancer Research, vol. 63, no. 21, pp. 7400–7409, 2003. View at Google Scholar · View at Scopus
  74. M. Christofidou-Solomidou, G. G. Pietra, C. C. Solomides et al., “Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs,” American Journal of Physiology, vol. 278, no. 4, pp. L794–L805, 2000. View at Google Scholar · View at Scopus
  75. S. Yu, C. He, Q. Lv et al., “pH and reduction-sensitive disulfide cross-linked polyurethane micelles for bio-triggered anti-tumor drug delivery,” Journal of Controlled Release, vol. 213, pp. e99–e100, 2015. View at Publisher · View at Google Scholar
  76. K. Sanka, R. R. Pragada, and P. R. Veerareddy, “A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis,” Journal of Microencapsulation, vol. 32, no. 8, pp. 794–803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. Z. Yuan, Z. Que, S. Cheng, R. Zhuo, and F. Li, “PH-triggered blooming of ‘nano-flowers’ for tumor intracellular drug delivery,” Chemical Communications, vol. 48, no. 65, pp. 8129–8131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Guha, N. Biswas, K. Bhattacharjee, P. Das, and K. Kuotsu, “In vitro evaluation of pH responsive Doxazosin loaded mesoporous silica nanoparticles: a smart approach in drug delivery,” Current Drug Delivery, vol. 13, no. 4, pp. 574–581, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Chen, K. Ai, J. Liu, G. Sun, Q. Yin, and L. Lu, “Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging,” Biomaterials, vol. 60, pp. 111–120, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. C. de la Torre, A. Agostini, L. Mondragón et al., “Temperature-controlled release by changes in the secondary structure of peptides anchored onto mesoporous silica supports,” Chemical Communications, vol. 50, no. 24, pp. 3184–3186, 2014. View at Publisher · View at Google Scholar
  81. Y. Jiao, Y. Sun, B. Chang, D. Lu, and W. Yang, “Redox- and temperature-controlled drug release from hollow mesoporous silica nanoparticles,” Chemistry, vol. 19, no. 45, pp. 15410–15420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Dong and J. I. Zink, “Simultaneous spectroscopic measurements of the interior temperature and induced cargo release from pore-restricted mesoporous silica nanoparticles,” Nanoscale, vol. 8, no. 20, pp. 10558–10563, 2016. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Aznar, L. Mondragõn, J. V. Ros-Lis et al., “Finely tuned temperature-controlled cargo release using paraffin-capped mesoporous silica nanoparticles,” Angewandte Chemie—nternational Edition, vol. 50, no. 47, pp. 11172–11175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. T. K. Jain, M. A. Morales, S. K. Sahoo, D. L. Leslie-Pelecky, and V. Labhasetwar, “Iron oxide nanoparticles for sustained delivery of anticancer agents,” Molecular Pharmaceutics, vol. 2, no. 3, pp. 194–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Murakami, X. Yu, S. Watanabe, T. Kato, Y. Inoue, and K. Sugawara, “Synthesis of thermosensitive polymer/mesoporous silica composite and its temperature dependence of anion exchange property,” Journal of Colloid and Interface Science, vol. 354, no. 2, pp. 771–776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Colilla, B. González, and M. Vallet-Regí, “Mesoporous silica nanoparticles for the design of smart delivery nanodevices,” Biomaterials Science, vol. 1, no. 2, pp. 114–134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Zintchenko, M. Ogris, and E. Wagner, “Temperature dependent gene expression induced by PNIPAM-based copolymers: potential of hyperthermia in gene transfer,” Bioconjugate Chemistry, vol. 17, no. 3, pp. 766–772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Nagase, J. Kobayashi, A. Kikuchi, Y. Akiyama, H. Kanazawa, and T. Okano, “Interfacial property modulation of thermoresponsive polymer brush surfaces and their interaction with biomolecules,” Langmuir, vol. 23, no. 18, pp. 9409–9415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Keerl, V. Smirnovas, R. Winter, and W. Richtering, “Copolymer microgels from mono- and disubstituted acrylamides: phase behavior and hydrogen bonds,” Macromolecules, vol. 41, no. 18, pp. 6830–6836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Hoare, J. Santamaria, G. F. Goya et al., “A magnetically triggered composite membrane for on-demand drug delivery,” Nano Letters, vol. 9, no. 10, pp. 3651–3657, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Baek, R. K. Singh, D. Khanal et al., “Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles,” Nanoscale, vol. 7, no. 34, pp. 14191–14216, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. C.-Y. Lai, B. G. Trewyn, D. M. Jeftinija et al., “A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules,” Journal of the American Chemical Society, vol. 125, no. 15, pp. 4451–4459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Giri, B. G. Trewyn, M. P. Stellmaker, and V. S.-Y. Lin, “Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles,” Angewandte Chemie—International Edition, vol. 44, no. 32, pp. 5038–5044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Torney, B. G. Trewyn, V. S.-Y. Lin, and K. Wang, “Mesoporous silica nanoparticles deliver DNA and chemicals into plants,” Nature Nanotechnology, vol. 2, no. 5, pp. 295–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Nadrah, U. Maver, A. Jemec et al., “Hindered disulfide bonds to regulate release rate of model drug from mesoporous silica,” ACS Applied Materials and Interfaces, vol. 5, no. 9, pp. 3908–3915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Bernardos, E. Aznar, M. D. Marcos et al., “Enzyme-responsive controlled release using mesoporous silica supports capped with lactose,” Angewandte Chemie—International Edition, vol. 48, no. 32, pp. 5884–5887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. E. Climent, A. Bernardos, R. Martínez-Máñez et al., “Controlled delivery systems using antibody-capped mesoporous nanocontainers,” Journal of the American Chemical Society, vol. 131, no. 39, pp. 14075–14080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. B. Sahoo, K. S. P. Devi, S. Dutta, T. K. Maiti, P. Pramanik, and D. Dhara, “Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications,” Journal of Colloid and Interface Science, vol. 431, pp. 31–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. G. R. Bardajee and Z. Hooshyar, “One-pot synthesis of biocompatible superparamagnetic iron oxide nanoparticles/hydrogel based on salep: characterization and drug delivery,” Carbohydrate Polymers, vol. 101, no. 1, pp. 741–751, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. U. Maver, M. Bele, D. Makovec, S. Čampelj, J. Jamnik, and M. Gaberšček, “Incorporation and release of drug into/from superparamagnetic iron oxide nanoparticles,” Journal of Magnetism and Magnetic Materials, vol. 321, no. 19, pp. 3187–3192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Makovec, S. Čampelj, M. Bele et al., “Nanocomposites containing embedded superparamagnetic iron oxide nanoparticles and rhodamine 6G,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 334, no. 1–3, pp. 74–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Talelli, C. J. F. Rijcken, T. Lammers et al., “Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery,” Langmuir, vol. 25, no. 4, pp. 2060–2067, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. L. Liu, P. Yu, Y. Zhang et al., “Doxorubicin-conjugated magnetic iron oxide nanoparticles for pH-sensitive and magnetic responsive drug delivery,” Journal of Controlled Release, vol. 213, article e67, 2015. View at Publisher · View at Google Scholar
  104. A. R. K. Sasikala, A. GhavamiNejad, A. R. Unnithan et al., “A smart magnetic nanoplatform for synergistic anticancer therapy: manoeuvring mussel-inspired functional magnetic nanoparticles for pH responsive anticancer drug delivery and hyperthermia,” Nanoscale, vol. 7, no. 43, pp. 18119–18128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  105. H. Kakwere, M. P. Leal, M. E. Materia et al., “Functionalization of strongly interacting magnetic nanocubes with (thermo)responsive coating and their application in hyperthermia and heat-triggered drug delivery,” ACS Applied Materials and Interfaces, vol. 7, no. 19, pp. 10132–10145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. D. E. Owens III and N. A. Peppas, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles,” International Journal of Pharmaceutics, vol. 307, no. 1, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. I. A. Alvi, J. Madan, D. Kaushik, S. Sardana, R. S. Pandey, and A. Ali, “Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis,” Anti-Cancer Drugs, vol. 22, no. 8, pp. 774–782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Bunker, A. Magarkar, and T. Viitala, “Rational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their PEGylation,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1858, no. 10, pp. 2334–2352, 2016. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Dorrani, O. B. Garbuzenko, T. Minko, and B. Michniak-Kohn, “Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy,” Journal of Controlled Release, vol. 228, pp. 150–158, 2016. View at Publisher · View at Google Scholar · View at Scopus
  110. K. Shi, J. Li, Z. Cao et al., “A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin alphavbeta3 for the treatment of melanoma,” Journal of Controlled Release, vol. 217, pp. 138–150, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. Z. Chen, T. Zhang, B. Wu, and X. Zhang, “Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes,” International Journal of Nanomedicine, vol. 11, pp. 991–1002, 2016. View at Publisher · View at Google Scholar · View at Scopus
  112. Y.-P. Fang, Y.-H. Tsai, P.-C. Wu, and Y.-B. Huang, “Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 144–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. T. Geetha, M. Kapila, O. Prakash, P. K. Deol, V. Kakkar, and I. P. Kaur, “Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer,” Journal of Drug Targeting, vol. 23, no. 2, pp. 159–169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  114. M. B. de Jesus, C. V. Ferreira, E. de Paula, D. Hoekstra, and I. S. Zuhorn, “Design of solid lipid nanoparticles for gene delivery into prostate cancer,” Journal of Controlled Release, vol. 148, no. 1, pp. e89–e90, 2010. View at Google Scholar · View at Scopus
  115. M. Sasidharan and K. Nakashima, “Core-shell-corona polymeric micelles as a versatile template for synthesis of inorganic hollow nanospheres,” Accounts of Chemical Research, vol. 47, no. 1, pp. 157–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  116. A. E. Felber, M.-H. Dufresne, and J.-C. Leroux, “PH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates,” Advanced Drug Delivery Reviews, vol. 64, no. 11, pp. 979–992, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. B. P. K. Reddy, H. K. S. Yadav, D. K. Nagesha, A. Raizaday, and A. Karim, “Polymeric micelles as novel carriers for poorly soluble drugs—a review,” Journal of Nanoscience and Nanotechnology, vol. 15, no. 6, pp. 4009–4018, 2015. View at Publisher · View at Google Scholar · View at Scopus
  118. K. Letchford and H. Burt, “A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 65, no. 3, pp. 259–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. P. Mi, N. Dewi, H. Yanagie et al., “Hybrid calcium phosphate-polymeric micelles incorporating gadolinium chelates for imaging-guided gadolinium neutron capture tumor therapy,” ACS Nano, vol. 9, no. 6, pp. 5913–5921, 2015. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Heta, K. Kumaki, H. Hifumi, D. Citterio, A. Tanimoto, and K. Suzuki, “Gadolinium containing photochromic micelles as potential magnetic resonance imaging traceable drug carriers,” Photochemistry and Photobiology, vol. 88, no. 4, pp. 876–883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. I. Singh, A. K. Rehni, R. Kalra, G. Joshi, and M. Kumar, “Dendrimers and their pharmaceutical applications—a review,” Pharmazie, vol. 63, no. 7, pp. 491–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Agarwal, A. Asthana, U. Gupta, and N. K. Jain, “Tumour and dendrimers: a review on drug delivery aspects,” Journal of Pharmacy and Pharmacology, vol. 60, no. 6, pp. 671–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. D. J. Bharali, M. Khalil, M. Gurbuz, T. M. Simone, and S. A. Mousa, “Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers,” International Journal of Nanomedicine, vol. 4, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. J. Yan, W. Li, and A. Zhang, “Dendronized supramolecular polymers,” Chemical Communications, vol. 50, no. 82, pp. 12221–12233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Kumari, S. Gupta, K. Achazi et al., “Dendronized multifunctional amphiphilic polymers as efficient nanocarriers for biomedical applications,” Macromolecular Rapid Communications, vol. 36, no. 2, pp. 254–261, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. E. Córdova-Mateo, O. Bertran, B. Zhang et al., “Interactions in dendronized polymers: intramolecular dominates intermolecular,” Soft Matter, vol. 10, no. 7, pp. 1032–1044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Yan, W. Li, K. Liu et al., “Thermoresponsive supramolecular dendronized polymers,” Chemistry, vol. 6, no. 12, pp. 3260–3269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. F. Liang and B. Chen, “A review on biomedical applications of single-walled carbon nanotubes,” Current Medicinal Chemistry, vol. 17, no. 1, pp. 10–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. J.-P. Tessonnier and D. S. Su, “Recent progress on the growth mechanism of carbon nanotubes: a review,” ChemSusChem, vol. 4, no. 7, pp. 824–847, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. Z. Zhu, L. Garcia-Gancedo, A. J. Flewitt, H. Xie, F. Moussy, and W. I. Milne, “A critical review of glucose biosensors based on carbon nanomaterials: carbon nanotubes and graphene,” Sensors, vol. 12, no. 5, pp. 5996–6022, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. D. Vairavapandian, P. Vichchulada, and M. D. Lay, “Preparation and modification of carbon nanotubes: review of recent advances and applications in catalysis and sensing,” Analytica Chimica Acta, vol. 626, no. 2, pp. 119–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  132. B. Dineshkumar, K. Krishnakumar, A. R. Bhatt et al., “Single-walled and multi-walled carbon nanotubes based drug delivery system: cancer therapy: a review,” Indian Journal of Cancer, vol. 52, no. 3, pp. 262–264, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. G. Cirillo, S. Hampel, U. G. Spizzirri, O. I. Parisi, N. Picci, and F. Iemma, “Carbon nanotubes hybrid hydrogels in drug delivery: a perspective review,” BioMed Research International, vol. 2014, Article ID 825017, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. T. Ukmar, U. Maver, O. Planinšek, V. Kaučič, M. Gaberšček, and A. Godec, “Understanding controlled drug release from mesoporous silicates: theory and experiment,” Journal of Controlled Release, vol. 155, no. 3, pp. 409–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Godec, U. Maver, M. Bele et al., “Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier,” International Journal of Pharmaceutics, vol. 343, no. 1-2, pp. 131–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. U. Maver, A. Godec, M. Bele et al., “Novel hybrid silica xerogels for stabilization and controlled release of drug,” International Journal of Pharmaceutics, vol. 330, no. 1-2, pp. 164–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Ghaderi, B. Ramesh, and A. M. Seifalian, “Fluorescence nanoparticles “quantum dots” as drug delivery system and their toxicity: a review,” Journal of Drug Targeting, vol. 19, no. 7, pp. 475–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. W. R. Algar, A. J. Tavares, and U. J. Krull, “Beyond labels: a review of the application of quantum dots as integrated components of assays, bioprobes, and biosensors utilizing optical transduction,” Analytica Chimica Acta, vol. 673, no. 1, pp. 1–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. E. Petryayeva, W. R. Algar, and I. L. Medintz, “Quantum dots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging,” Applied Spectroscopy, vol. 67, no. 3, pp. 215–252, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. A. Tan, L. Yildirimer, J. Rajadas, H. De La Peña, G. Pastorin, and A. Seifalian, “Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine,” Nanomedicine, vol. 6, no. 6, pp. 1101–1114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. M. J. Kim, J. Y. Lee, U. Nehrbass, R. Song, and Y. Choi, “Detection of melanoma using antibody-conjugated quantum dots in a coculture model for high-throughput screening system,” Analyst, vol. 137, no. 6, pp. 1440–1445, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. S. Steponkiene, S. Kavaliauskiene, R. Purviniene, R. Rotomskis, and P. Juzenas, “Quantum dots affect expression of CD133 surface antigen in melanoma cells,” International Journal of Nanomedicine, vol. 6, pp. 2437–2444, 2011. View at Google Scholar · View at Scopus
  143. M. Singh, D. C. C. Harris-Birtill, S. R. Markar, G. B. Hanna, and D. S. Elson, “Application of gold nanoparticles for gastrointestinal cancer theranostics: a systematic review,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 11, no. 8, pp. 2083–2098, 2015. View at Publisher · View at Google Scholar · View at Scopus
  144. M. R. K. Ali, S. R. Panikkanvalappil, and M. A. El-Sayed, “Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin,” Journal of the American Chemical Society, vol. 136, no. 12, pp. 4464–4467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  145. A. Kumar, H. Ma, X. Zhang et al., “Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment,” Biomaterials, vol. 33, no. 4, pp. 1180–1189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. J. Lee, D. K. Chatterjee, M. H. Lee, and S. Krishnan, “Gold nanoparticles in breast cancer treatment: promise and potential pitfalls,” Cancer Letters, vol. 347, no. 1, pp. 46–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. E. C. Dreaden, B. E. Gryder, L. A. Austin et al., “Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells,” Bioconjugate Chemistry, vol. 23, no. 8, pp. 1507–1512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. M. L. Mojica Pisciotti, E. Lima Jr., M. Vasquez Mansilla et al., “In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 102, no. 4, pp. 860–868, 2014. View at Publisher · View at Google Scholar · View at Scopus
  149. Y. Mi, X. Liu, J. Zhao, J. Ding, and S.-S. Feng, “Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers,” Biomaterials, vol. 33, no. 30, pp. 7519–7529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. X. He, F. Liu, L. Liu, T. Duan, H. Zhang, and Z. Wang, “Lectin-conjugated Fe2O3@Au core@shell nanoparticles as dual mode contrast agents for in vivo detection of tumor,” Molecular Pharmaceutics, vol. 11, no. 3, pp. 738–745, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. H. Basti, L. Ben Tahar, L. S. Smiri et al., “Catechol derivatives-coated Fe3O4 and γ-Fe2O3 nanoparticles as potential MRI contrast agents,” Journal of Colloid and Interface Science, vol. 341, no. 2, pp. 248–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. Z.-Y. Wang, J. Song, and D.-S. Zhang, “Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells,” World Journal of Gastroenterology, vol. 15, no. 24, pp. 2995–3002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  153. J. Zhou, J. Li, X. Ding et al., “Multifunctional Fe2O3@PPy-PEG nanocomposite for combination cancer therapy with MR imaging,” Nanotechnology, vol. 26, no. 42, p. 425101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  154. Y.-H. Ma, H.-Y. Peng, R.-X. Yang, and F. Ni, “Preparation of lysine-coated magnetic fe2o3 nanoparticles and influence on viability of a549 lung cancer cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 20, pp. 8981–8985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Y. Yan, M. M. Chen, J. G. Fan et al., “Therapeutic mechanism of treating smmc-7721 liver cancer cells with magnetic fluid hyperthermia using Fe2O3 nanoparticles,” Brazilian Journal of Medical and Biological Research, vol. 47, no. 11, pp. 947–959, 2014. View at Publisher · View at Google Scholar · View at Scopus
  156. A. B. Salunkhe, V. M. Khot, and S. H. Pawar, “Magnetic hyperthermia with magnetic nanoparticles: a status review,” Current Topics in Medicinal Chemistry, vol. 14, no. 5, pp. 572–594, 2014. View at Publisher · View at Google Scholar · View at Scopus
  157. A. J. Giustini, A. A. Petryk, S. M. Cassim, J. A. Tate, I. Baker, and P. J. Hoopes, “Magnetic nanoparticle hyperthermia in cancer treatment,” Nano LIFE, vol. 01, no. 01n02, pp. 17–32, 2010. View at Publisher · View at Google Scholar
  158. R. Hu, S. Ma, X. Ke, H. Jiang, D. Wei, and W. Wang, “Effect of interleukin-2 treatment combined with magnetic fluid hyperthermia on Lewis lung cancer-bearing mice,” Biomedical Reports, vol. 4, no. 1, pp. 59–62, 2016. View at Publisher · View at Google Scholar
  159. M. Bañobre-López, A. Teijeiro, and J. Rivas, “Magnetic nanoparticle-based hyperthermia for cancer treatment,” Reports of Practical Oncology and Radiotherapy, vol. 18, no. 6, pp. 397–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  160. A. Espinosa, R. Di Corato, J. Kolosnjaj-Tabi, P. Flaud, T. Pellegrino, and C. Wilhelm, “Duality of iron oxide nanoparticles in cancer therapy: amplification of heating efficiency by magnetic hyperthermia and photothermal bimodal treatment,” ACS Nano, vol. 10, no. 2, pp. 2436–2446, 2016. View at Publisher · View at Google Scholar · View at Scopus
  161. A. A. Petryk, A. J. Giustini, R. E. Gottesman, P. A. Kaufman, and P. J. Hoopes, “Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment,” International Journal of Hyperthermia, vol. 29, no. 8, pp. 845–851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  162. S. K. Calderwood, M. A. Stevenson, and A. Murshid, “Heat shock proteins, autoimmunity, and cancer treatment,” Autoimmune Diseases, vol. 1, no. 1, Article ID 486069, 2012. View at Publisher · View at Google Scholar · View at Scopus
  163. C. T. Avedisian, R. E. Cavicchi, P. L. McEuen, and X. Zhou, “Nanoparticles for cancer treatment: role of heat transfer,” Annals of the New York Academy of Sciences, vol. 1161, pp. 62–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. M. Kawashita, S. Domi, Y. Saito et al., “In vitro heat generation by ferrimagnetic maghemite microspheres for hyperthermic treatment of cancer under an alternating magnetic field,” Journal of Materials Science: Materials in Medicine, vol. 19, no. 5, pp. 1897–1903, 2008. View at Publisher · View at Google Scholar · View at Scopus
  165. K. Hayashi, M. Nakamura, H. Miki et al., “Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release,” Theranostics, vol. 4, no. 8, pp. 834–844, 2014. View at Publisher · View at Google Scholar · View at Scopus
  166. J. Chen, R. Shao, X. D. Zhang, and C. Chen, “Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics,” International Journal of Nanomedicine, vol. 8, pp. 2677–2688, 2013. View at Publisher · View at Google Scholar · View at Scopus
  167. M. B. R. Pierre, A. C. Tedesco, J. M. Marchetti, and M. V. L. B. Bentley, “Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study,” BMC Dermatology, vol. 1, article 5, 2001. View at Publisher · View at Google Scholar · View at Scopus
  168. A. Y. Bedikian, N. E. Papadopoulos, K. B. Kim et al., “A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma,” Melanoma Research, vol. 18, no. 6, pp. 400–404, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. L. A. Huber, T. A. Pereira, D. N. Ramos et al., “Topical skin cancer therapy using doxorubicin-loaded cationic lipid nanoparticles and iontophoresis,” Journal of Biomedical Nanotechnology, vol. 11, no. 11, pp. 1975–1988, 2015. View at Publisher · View at Google Scholar · View at Scopus
  170. R. H. Wilson, R. Plummer, J. Adam et al., “Phase I and pharmacokinetic study of NC-6004, a new platinum entity of cisplatin-conjugated polymer forming micelles,” Journal of Clinical Oncology, vol. 26, no. 15, supplement 1, abstract 2573, 2008, Proceedings of the ASCO Annual Meeting. View at Google Scholar
  171. H. Yang, “Targeted nanosystems: advances in targeted dendrimers for cancer therapy,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 12, no. 2, pp. 309–316, 2016. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Somani and C. Dufès, “Applications of dendrimers for brain delivery and cancer therapy,” Nanomedicine, vol. 9, no. 15, pp. 2403–2414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  173. N. G. Sahoo, H. Bao, Y. Pan et al., “Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study,” Chemical Communications, vol. 47, no. 18, pp. 5235–5237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. B. B. Choi, M. S. Kim, K. W. Song et al., “Targeting NEU protein in melanoma cells with non-thermal atmospheric pressure plasma and gold nanoparticles,” Journal of Biomedical Nanotechnology, vol. 11, no. 5, pp. 900–905, 2015. View at Publisher · View at Google Scholar · View at Scopus
  175. S. Labala, P. K. Mandapalli, A. Kurumaddali, and V. V. K. Venuganti, “Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma,” Molecular Pharmaceutics, vol. 12, no. 3, pp. 878–888, 2015. View at Publisher · View at Google Scholar · View at Scopus
  176. Y.-F. Rao, W. Chen, X.-G. Liang et al., “Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier,” Small, vol. 11, no. 2, pp. 239–247, 2015. View at Publisher · View at Google Scholar · View at Scopus
  177. J. Funkhouser, “Reinventing pharma: the theranostic revolution,” Current Drug Discovery, vol. 2, pp. 17–19, 2002. View at Google Scholar · View at Scopus
  178. Z.-R. Lu, “Theranostics: fusion of therapeutics and diagnostics,” Pharmaceutical Research, vol. 31, no. 6, pp. 1355–1357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  179. S. Jeelani, R. C. Jagat Reddy, T. Maheswaran, G. S. Asokan, A. Dany, and B. Anand, “Theranostics: a treasured tailor for tomorrow,” Journal of Pharmacy and Bioallied Sciences, vol. 6, supplement 1, pp. S6–S8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  180. B. G. Feagan, M. Lémann, R. Befrits et al., “Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report,” Inflammatory Bowel Diseases, vol. 18, no. 1, pp. 152–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. V. von Felbert, D. Bauerschlag, N. Maass et al., “A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR,” Journal of Cancer Research and Clinical Oncology, vol. 142, no. 5, pp. 1003–1011, 2016. View at Publisher · View at Google Scholar · View at Scopus
  182. L. Vannucci, E. Falvo, M. Fornara et al., “Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles,” International Journal of Nanomedicine, vol. 7, pp. 1489–1509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  183. M. Ma, Y. Hao, N. Liu et al., “A novel lipid-based nanomicelle of docetaxel: Evaluation of antitumor activity and biodistribution,” International Journal of Nanomedicine, vol. 7, pp. 3389–3398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  184. R. Bazak, M. Houri, S. El Achy, S. Kamel, and T. Refaat, “Cancer active targeting by nanoparticles: a comprehensive review of literature,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 5, pp. 769–784, 2015. View at Publisher · View at Google Scholar · View at Scopus
  185. S. Sultana, M. R. Khan, M. Kumar, S. Kumar, and M. Ali, “Nanoparticles-mediated drug delivery approaches for cancer targeting: a review,” Journal of Drug Targeting, vol. 21, no. 2, pp. 107–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  186. H. Wang, D.-K. Lee, K.-Y. Chen et al., “Mechanism-independent optimization of combinatorial nanodiamond and unmodified drug delivery using a phenotypically driven platform technology,” ACS Nano, vol. 9, no. 3, pp. 3332–3344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  187. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O. C. Farokhzad, “Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology,” Advanced Drug Delivery Reviews, vol. 66, pp. 2–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  188. F. K. dos Santos, M. H. Oyafuso, C. P. Kiill, M. P. Daflon-Gremião, and M. Chorilli, “Nanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases—a review,” Current Nanoscience, vol. 9, no. 1, pp. 159–167, 2013. View at Google Scholar · View at Scopus
  189. D. E. Speiser, K. Schwarz, P. Baumgaertner et al., “Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients,” Journal of Immunotherapy, vol. 33, no. 8, pp. 848–858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  190. T. M. Allen and P. R. Cullis, “Liposomal drug delivery systems: from concept to clinical applications,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 36–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  191. K. S. Siu, D. Chen, X. Zheng et al., “Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma,” Biomaterials, vol. 35, no. 10, pp. 3435–3442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  192. H. S. Jung, W. H. Kong, D. K. Sung et al., “Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer,” ACS Nano, vol. 8, no. 1, pp. 260–268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  193. P. Sharma, N. K. Mehra, K. Jain, and N. K. Jain, “Biomedical applications of carbon nanotubes: a critical review,” Current Drug Delivery, vol. 13, no. 6, pp. 796–817, 2016. View at Publisher · View at Google Scholar · View at Scopus
  194. F. Navarro-Pardo, A. L. Martinez-Hernandez, and C. Velasco-Santos, “Carbon nanotube and graphene based polyamide electrospun nanocomposites: a review,” Journal of Nanomaterials, vol. 2016, Article ID 3182761, 16 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  195. E. Amstad, M. Textor, and E. Reimhult, “Stabilization and functionalization of iron oxide nanoparticles for biomedical applications,” Nanoscale, vol. 3, no. 7, pp. 2819–2843, 2011. View at Publisher · View at Google Scholar · View at Scopus
  196. H. Zhao, Z. Li, B. Yang, J. Wang, and Y. Li, “Synthesis of dual-functional targeting probes for cancer theranostics based on iron oxide nanoparticles coated by centipede-like polymer connected with pH-responsive anticancer drug,” Journal of Biomaterials Science, Polymer Edition, vol. 26, no. 16, pp. 1178–1189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  197. Y. Ling, K. Wei, Y. Luo, X. Gao, and S. Zhong, “Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy,” Biomaterials, vol. 32, no. 29, pp. 7139–7150, 2011. View at Publisher · View at Google Scholar · View at Scopus